Latest News

Combining GLP-1 RA therapy with healthy lifestyle habits significantly reduces cardiovascular risk in type 2 diabetes patients, enhancing heart health outcomes.

As an adjunct to depression treatment, lumateperone reduced depressive symptoms and improved quality of life.

Enfortumab vedotin-ejfv has transformed treatment in locally advanced and metastatic urothelial carcinoma from decades-long platinum-based chemotherapy to the new standard of care combination of antibody-drug conjugate and PD-1/PD-L1 inhibitor.

Low-dose aspirin significantly reduces heart attack, stroke, and death risks in adults with type 2 diabetes and elevated cardiovascular risk.

Although further data will be presented in 2026, lifileucel shows promise as a 1-time treatment for advanced non–small cell lung cancer (NSCLC).

Oral semaglutide shows promise in enhancing glucose control and reducing cardiovascular risks.

Razumab, a ranibizumab biosimilar, shows comparable efficacy to its innovator counterpart in treating myopic choroidal neovascular membrane (mCNVM), offering a cost-effective solution.

Experts analyze the effects of MFN tariffs and DTC channels on drug pricing, patient access, and pharmacy operations, revealing critical industry insights.

Linaclotide has been approved to treat patients aged 7 and older with irritable bowel syndrome with constipation, becoming the first treatment for this indication in this age group.

Multiplex respiratory virus testing enhances clinical decision-making for RSV in community hospitals.

CAR-T and BsAb therapies revolutionize multiple myeloma treatment but pose infection risks, necessitating vigilant monitoring and tailored prevention strategies.

Maternal COVID-19 infection raises concerns about neurodevelopmental disorders in children, emphasizing the need for effective fever and infection management during pregnancy.

Research highlights significant barriers to contraceptive use and reproductive health management for women with chronic kidney disease (CKD), urging improved nephrology care.

Long-term melatonin use for insomnia raises heart failure risks, highlighting the need for careful evaluation of sleep aids and underlying health issues.

Survivors of ischemic stroke had a lower risk of major adverse cardiovascular events (MACE) when achieving low levels of low-density lipoprotein cholesterol (LDL-C).

Travelers to Europe face rising risks of tick-borne encephalitis, emphasizing the critical need for vaccinations and awareness of preventive measures.

Explore the rising prevalence of diabetes in the US, its various types, and the critical role pharmacists play in patient care.

The FDA has approved doxecitine-doxribtimine powder for the treatment of patients with thymidine kinase 2 deficiency developing symptoms at or before the age of 12.

RSV infections in multiple myeloma patients delay treatment but do not increase mortality, highlighting the need for further research on infection management.

In children and adolescents, reinfection with COVID-19 increased the risk of worsened long COVID outcomes.